FDA Drugs (New Approvals & NDA)Original article
CDER Nitrosamine Impurity Acceptable Intake Limits
RegulatoryNeutral
AI Analysis
Summary
The FDA's Center for Drug Evaluation and Research (CDER) released updated guidance on acceptable intake limits for nitrosamine drug substance-related impurities (NDSRIs). This is a routine regulatory guidance update affecting drug manufacturing and quality standards.
Outcome Details
Updated guidance on acceptable intake limits for nitrosamine impurities in drug substances
Importance:4/10
Sentiment:
0.00
FDACDERNitrosamineImpuritiesGuidanceDrug Safety
Read the original article
Published by FDA Drugs (New Approvals & NDA) on July 29, 2026 3:32 PM